IMU 9.09% 10.0¢ imugene limited

pixiemops chat

  1. 4,996 Posts.

    pixie this extact from their latest announ. says it all.
    based on this statement they must be in advanced negotiations with someone otherwise how would they know that commercialisation costs will be bourne by their partner.what would happen if a partner didnt agree to this. i suspect a development in this area ie. PRRS soon. i suspect merial might be interested.

    my opinion disclaimer at the bottom

    progress to regulatory trials in the principal target markets of the USA and Europe. These are likely to be conducted with commercial partners in the northern hemisphere. PRRS does not currently occur in Australia. "Negotiations will be advanced more rapidly with large global animal health companies to progress external validation trials prior to licensing arrangements. Costs for the PRRS vaccine product development will be borne by the licensing partner," stated Dr Lamb.
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Mkt cap ! $716.4M
Open High Low Value Volume
11.0¢ 11.5¢ 10.0¢ $4.569M 43.47M

Buyers (Bids)

No. Vol. Price($)
81 11802437 10.0¢

Sellers (Offers)

Price($) Vol. No.
10.5¢ 1548686 12
View Market Depth
Last trade - 16.10pm 01/12/2023 (20 minute delay) ?
-0.010 ( 8.14 %)
Open High Low Volume
11.5¢ 11.5¢ 10.0¢ 23114205
Last updated 16.09pm 01/12/2023 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.